Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible
Immunic Inc (NASDAQ:IMUX) will be present at two conferences in June. At the BIO International Convention in San Diego, Jessica Breu, VP of Investor...
NEW YORK, May 6, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...
Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joins Proactive's Stephen Gunnion with more on the serious and lifelong nature of celiac disease to mark Celiac...